PREDNISOLONE

Product Description

Niksan pharmaceutical is one of the leading manufacturer, supplier, distributor and exporter of Prednisolone API and finished formulation as all dosage forms. Our product Prednisolone is widely used and appreciated by our group companies and also our customers and users all around the nations. We offer the Prednisolone in very affordable price.

Niksan Pharmaceutical is the suppliers, manufacturer, exporter and trader in the domestic level as well as the international market.

Niksan Pharmaceutical provides Prednisolone API in all over Indian states like Uttara hand, Pondicherry, Kerala, AndhraPrades, Punjab, Himachal Pradesh, Chhattisgarh, Jammu & Kashmir, Haryana, Telangana, Goa, TamilNadu, Jharkhand, Karnataka, Rajasthan, Chandigarh, Gujarat, Maharashtra, UttarPradesh, Odisha, Delhi, West Bengal, Assam, Manipur, Bihar, Madhya Pradesh and many other state.

Niksan Pharmaceutical also exports Prednisolone API in world other countries like Zimbabwe, Trinidad & Tobago, Zambia, Ghana, Kenya, Singapore, Mauritius, Australia, Malaysia, Tanzania, Uganda, Nigeria, United Kingdom, Ireland, Puerto Rico, Iraq, Sri Lanka, France, Nepal, Sudan, Jordan, Thailand, Qatar, Oman, United Arab Emirates, Hong Kong, Taiwan, United States, Kuwait, Bangladesh, Saudi Arabia, Belgium, Pakistan, Morocco, Philippine, Algeria, Canada, New Zealand, South Africa, South Korea, Egypt, Norway, Indonesia, Iran, Switzerland, Vietnam, Greece, Denmark, Israel and many other countries.

Prednisolone is steroid medicine which is used to treatment of allergies, inflammatory conditions, autoimmune disorders, and cancers.

SYNONYMS: Delta-Dehydrocortisol, Delta-Dehydrohydrocortisone, Delta-Hydrocortisone, Delta (1)-Dehydrocortisol, Delta (1)-Hydrocortisone, Hydroretrocortine, Metacortandralone, Prdl, Prednisolona, Prednisolone, Prednisolonum

IUPAC NAME: (1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-1-(2-hydroxyacetyl)-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one

CAS NO: 50-24-8

FORMULA: C21H28O5

MOLECULAR MASS: 360.44 g/mol

APPLICATIONS OF Prednisolone: Prednisolone is used to treatment of immune system disorders, skin and eye conditions, arthritis, blood problems, breathing problem and cancer. It is used to treatment of some allergic reaction.

HOW TO USE: Take single dose in one day. Prednisolone is available as form of solutions and tablet so you can take by mouth with or without food.

HOW PREDNISOLONE WORKS: Prednisolone work by lowering the activity of the immune system.

CONTRAINDI CATIONS: If you have any untreated tuberculosis, inactive tuberculosis, herpes simplex infection of the eye, a herpes simplex infection and an infection due to a fungus kindly avoid Prednisolone. If you have low amount of potassium or magnesium in your blood or body kindly avoid Prednisolone.

PHARMA COKINETICS OF PREDNISOLONE: Absorption is approximately 70%after oral administration. Half-life of Prednisolone is 2.1 to 3.5 hours. Peak plasma concentration of Prednisolone is approximately 113-1343mg/ml. 98%Prednisolone eliminate via urine.

SIDE EFFECTS OF Prednisolone: Common side effect of Prednisolone is weight gain, Indigestion, sleep problems, Restlessness and sweating a lot.

PRECAUTIONS: Before using this medication, tell your doctor or pharmacist your medical history. This drug may make you dizzy so avoid alcohol and do not drive and do not handle machinery. In the rare case you may infected by Prednisolone. This medication may effect on children's height.

CDSCO APPROVAL: Levofloxacin(15mg) + Prednisolone Acetate 10mg per ml eye drops are approved by CDSCO in India in 11.07.2007

Clotrimazole (10mg) + Methylprednisolone acoelomate 1mg/gm of cream is approved by CDSCO in India in 12.07.2007

Docetaxal injection is approved by CDSCO in India in 09.03.2005

MoxifloxacinHCl (5mg) + Prednisolone Acetate (10mg) per ml. (eye drops) are approved by CDSCO in India in 16.10.2007

Prednisolone stearoyl glycolate tablet is approved by CDSCO in India in November-1970

Mupirocin(2%) + Methyl prednisolone Aceponate (0.1%) Cream is approved by CDSCO in India in31.10.2007

Methylprednisolone aceponate-1mg + salicylic acid-50mg tablet is approved by CDSCO in India in 19.11.2007

Methyl prednisolone aceponate-1mg + Mupirocin-20mg cream is approved by CDSCO in India in 21.11.2007

Prednisolone Sodium Phosphate Orally Disintegrating Tablet is approved by CDSCO in India in26.11.2009

Prednisolone tablet is approved by CDSCO in India in December-1971

Methyl prednisolone tablet is approved by CDSCO in India in March-1978

Methyl prednisolone acetate tablet is approved by CDSCO in India in November-1962

Methyl prednisolone Tablet 8mg is approved by CDSCO in India in 01.09.2009

Prednisolone+ Ofloxacin tablet is approved by CDSCO in India in 2003

Methylprednisolone Acrponate topical solution 0.1%is approved by CDSCO in India in 09.04.2007

Gatifloxacin( 0.3%) + Prednisolone Acetate (1%) eye drops are approved by CDSCO in India in 02.06.2006

Prednisolone stearoyl glycolate tablet is approved by CDSCO in India in February-1971

Methylprednisolone Acoelomate Cream (0.1%) is approved by CDSCO in India in 15.06.2006

Lincomycin +Neomycin + Methyl prednisolone is approved by CDSCO in India inMarch-1989

FORMULATIONS AVAILABLE IN MARKET:

Prednisolone 10 MG tablets

Prednisolone 5 MG tablets

Prednisolone 1 %W/V solutions

Prednisolone 30 MG tablets

Prednisolone 20 MG tablets

Prednisolone 40 MG tablets

Prednisolone 1 MG tablets

Prednisolone 2 MG tablets

Ofloxacin 3MG+Prednisolone 10 MG /ML solutions

Prednisolone 5 MG /5ML solutions

Prednisolone 15 MG /5MLsolutions

Prednisolone 2.5 MG tablet

Moxifloxacin 0.5 %W/V+Prednisolone 1 %W/V solutions

Gatifloxacin 0.3 %W/V+Prednisolone 1 %W/V solutions

Chloramphenicol 0.5 %W/V+Prednisolone 0.1 %W/V solutions

Note: Product protected by valid patents are not offered for sale in countries where such patents are still valid and its liability is at Buyers Risk.